Board of Governors

The Honourable Michael Egan (Chair)
Mr Egan is currently the Vice Chancellor of Macquarie University and is a former Treasurer of NSW. During his 25-year parliamentary career, Mr Egan held a number of ministerial positions and still remains the longest serving Treasurer of NSW (1995-2005).

Mr John Samaha (Deputy Chair)
Mr Samaha has advised business and government on legal and strategic matters and risk management since 1984. He has represented clients in disputes, Court proceedings, mediations and regulatory investigations. He was at a leading firm, Mallesons Stephen Jaques, from 1988 to 2007 where he was a partner from 1995 to 2007.

Dr Teresa Anderson
Dr Anderson is the Director of Clinical Operations, Sydney South West Area Health Services. She is on the State Surgical Taskforce and a Board member of the Centre for Primary Health Care and Equity, University of UNSW and was previously the General Manager of Liverpool Hospital.

The Honourable John Brown AO FAMI
Formerly the Member for Parramatta in the Federal House of Representatives for 13 years from 1977, Mr Brown held various Ministerial portfolios including Arts, Sports, Environment and Territories. In 1986, he was named Australian of the Year by The Australian newspaper and was the founding Chairman of the Tourism Task Force (now the Tourism and Transport Forum) and is the Founder and Patron of the Sport and Tourism Youth Foundation.

Mr Alastair Davidson MICA (Scot)
Mr Davidson has held executive positions in the banking and financial services industry for 15 years in the UK, US and Australia. He is currently Managing Director of Aurora Funds Management in Sydney. Prior to this, Mr Davidson was at Salomon Smith Barney in Sydney, where he spent eight years as co-head of its new product group, specialising in equity derivatives.

Mr Geoff Dixon
Mr Dixon is the Chief Executive Officer and Managing Director of Qantas. Prior to this, he was Chief Executive Designate (from November 2000), after serving as Deputy Chief Executive for two years. Mr Dixon is a Director of Publishing and Broadcasting Limited, Crown Limited (formerly Arterial Limited), Air Pacific Limited and a number of controlled entities of the Qantas Group. He is on the Governing Board of the International Air Transport Association.

Ms Di Gill
Ms Gill is Executive Director of Royal Prince Alfred Hospital, one of the largest tertiary referral hospitals in NSW. She has extensive experience in health having previously held the position of Director of Nursing Operations at Royal Prince Alfred Hospital. She is a member of the Australian Council of Healthcare Standards, the NSW Health Department Clinical Ethics Advisory Panel and the NSW Health Department Sustainable Access Health Priority Taskforce. In addition, she is also an Associate Fellow of the Australian College of Health Service Executives.

Professor John Horvath AO
Professor Horvath is the Chief Medical Officer for the Australian Government. He is the principal medical adviser to the Minister of Health and the Department of Health and Ageing across the full range of professional health issues, including health and medical research, public health, medical workforce, quality of care, evidence-based medicine, biosecurity issues and an outcomes-focused health system. Prior to his appointment as Chief Medical Officer in September of 2003, Professor Horvath was a Professor of Renal Medicine at the University of Sydney and a specialist renal physician at the Royal Prince Alfred Hospital. He was awarded an Order of Australia in January 2001 for his services to medicine.

Mr Graham Kelly
Mr Kelly is non-executive Chairman of Tishman Speyer Office Trust, Centrebet International Ltd, Colonial First State Private Capital Ltd and a non-executive Director of several non-listed companies including FreshFood Australia Holdings Pty Ltd and Oasis Fund Management Ltd. He is a consultant to Freehills law firm, Inspector of the Independent Commission Against Corruption and has been a Director of the Medical Research and Compensation Foundation. Mr Kelly has previously served as Managing Partner of the Sydney/Brisbane/Canberra offices Freehills and National Chairman of the firm.

Mr Neil Lawrence
Mr Lawrence is currently the Executive Creative Director of Australia's largest advertising group, STW Group, having worked in the advertising industry for over 20 years. His clients include: The Commonwealth Bank, Apple, Sony, Mitsubishi, The Federal Government, Cadbury, Masterfoods, St George Bank, Colgate, American Express, AAPT, FOXTEL, The Australian, the Sydney Morning Herald, Qantas and many charities such as the Fred Hollows Foundation and the Garvan Institute. In 2007, Mr Lawrence was named Australian Marketer of the Year for his crafting of the Australia Labour Party's successful Kevin07 federal election campaign.

Associate Professor Kelly-Anne Phillips
Associate Professor Phillips is currently the inaugural Colebatch Clinical Research Fellow of The Cancer Council Victoria and a medical oncologist and researcher at the Peter MacCallum Cancer Centre. Her major areas of research are breast cancer genetics and survivorship issues in breast cancer, particularly prevention of chemotherapy-induced menopause and cognitive dysfunction. She leads several international and national studies in these areas.

Professor Bruce Robinson
Professor Robinson is Dean of the Faculty of Medicine, University of Sydney and Head of the Cancer Genetic Laboratory at the Kolling Institute. In 2003, he was awarded the Daiichi Prize by the Asia and Oceania Thyroid Association for this work on the pathogenesis of thyroid cancer. Professor Robinson is the Founding Chairman of Hoc Mai, the Australia Vietnam Medical Foundation, which sponsors and supports medical nursing, allied health and scientific exchanges between Australia and Vietnam. He is a Fellow of the Australian Institute of Company Directors.

Professor Mathew Vadas
Professor Vadas trained in medicine at the University of Sydney and as a physician at the Royal Prince Alfred Hospital before completing a doctorate at the Walter and Eliza Hall Institute in Melbourne. After postdoctoral work at Harvard, he returned to Australia and built up a significant research enterprise in Adelaide. He was a chief initiator and Inaugural Director of the Hanson Centre for Cancer Research (now Hanson Institute). Professor Vadas has contributed strongly to the Australian biotechnology sector, being involved variously as founder, Chair of the Scientific Advisory Board and acting CEO of two ASX listed biotechnology companies. He is chair of the Medical Research Advisory Board of the Australian Cancer Research Foundation and on the Board of governors of the SMILE Foundation.